AU2001273202A1 - Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury - Google Patents

Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury

Info

Publication number
AU2001273202A1
AU2001273202A1 AU2001273202A AU7320201A AU2001273202A1 AU 2001273202 A1 AU2001273202 A1 AU 2001273202A1 AU 2001273202 A AU2001273202 A AU 2001273202A AU 7320201 A AU7320201 A AU 7320201A AU 2001273202 A1 AU2001273202 A1 AU 2001273202A1
Authority
AU
Australia
Prior art keywords
ascorbic acid
regeneration
injury
salts
promote cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273202A
Inventor
Grazyna Nowak
Ricky Schnellmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Arkansas
Original Assignee
University of Arkansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Arkansas filed Critical University of Arkansas
Publication of AU2001273202A1 publication Critical patent/AU2001273202A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001273202A 2000-07-05 2001-07-05 Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury Abandoned AU2001273202A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21596000P 2000-07-05 2000-07-05
US60215960 2000-07-05
PCT/US2001/021337 WO2002001954A1 (en) 2000-07-05 2001-07-05 Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury

Publications (1)

Publication Number Publication Date
AU2001273202A1 true AU2001273202A1 (en) 2002-01-14

Family

ID=22805087

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273202A Abandoned AU2001273202A1 (en) 2000-07-05 2001-07-05 Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury

Country Status (3)

Country Link
US (1) US20020019372A1 (en)
AU (1) AU2001273202A1 (en)
WO (1) WO2002001954A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020557A1 (en) * 2002-03-15 2003-09-15 Acraf USE OF A SALT OF L-ASCORBIC ACID TO PREPARE A PHARMACEUTICAL COMPOSITION FOR TOPICAL OPHTHALMIC USE CAPABLE OF IMPROVING THE LEVEL D
US20050256186A1 (en) * 2004-03-05 2005-11-17 Fumie Morishige Prevention of and countermeasures against mitochondrial disease
GB2450477A (en) * 2007-06-18 2008-12-31 Ethicon Inc Stabilized wound dressing
US8034363B2 (en) * 2008-12-11 2011-10-11 Advanced Technologies And Regenerative Medicine, Llc. Sustained release systems of ascorbic acid phosphate
GB2470040A (en) 2009-05-06 2010-11-10 Systagenix Wound Man Ip Co Bv Wound dressing material comprising N-acetyl cysteine
CA2937613C (en) 2013-01-23 2021-03-02 Bottled Science Limited Skin enhancing beverage composition
US20190099295A1 (en) * 2017-09-29 2019-04-04 Johnson & Johnson Consumer Inc. Extensible Dressings
TWI645850B (en) * 2017-10-03 2019-01-01 長庚醫療財團法人林口長庚紀念醫院 Use of ascorbic acid for the preparation of ophthalmic compositions for protecting corneal endothelial cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
EP0282746A1 (en) * 1987-02-19 1988-09-21 Takeda Chemical Industries, Ltd. Method for producing artificial cultured tissue

Also Published As

Publication number Publication date
WO2002001954A1 (en) 2002-01-10
US20020019372A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
HK1057214A1 (en) New mandelic acid derivatives and their use as throbin inhibitors
EG24169A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
PT1143954E (en) USE OF NOCOTINIC ACID DERIVATIVES FOR THE TREATMENT OF DNA DAMAGE IN SKIN CELLS
SI1371647T1 (en) Pyridine-3-carboxylic acid derivatives and their use as intermediates
PL1641916T3 (en) Regeneration and repair of neural tissue using postpartum-derived cells
ID26427A (en) BENDET SHEETS USED IN USE ONCE
AU5455200A (en) The use of encapsulated acid in acid fracturing treatments
ATE405996T1 (en) REDUCING THE RATIO OF PEAK POWER TO AVERAGE POWER IN A MOBILE COMMUNICATIONS SYSTEM
PL355998A1 (en) Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
AU2001273202A1 (en) Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury
HUP0105302A2 (en) 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors, their use and process for their preparation
EE200100514A (en) Inhibitors of LFA-1 binding to ICAMs and their use
AU2002363523A1 (en) Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
PL349769A1 (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors
PL364171A1 (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
AU2001235437A1 (en) Isothiazolecarboxylic acid derivatives and their use as microbicides
AU2001291688A1 (en) (meth)acrylic acid derivatives and their polymers suitable for use in the manufacture of paper
AU2002222827A1 (en) Method and device to resist sulfatizing in electric accumulators
AU2001242847A1 (en) Polyphosphate for use in promoting wound healing and scar abatement
AU3694895A (en) Nox destruction in sulphuric acid
PL356092A1 (en) Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
AU2002358217A1 (en) Improvements in or relating to energy storage devices
AU2003297074A1 (en) Transdermal buprenorphine to treat pain in sickle cell crisis
AU2002251681A1 (en) Production and use of dopaminergic cells to treat dopaminergic deficiencies
HK1047107B (en) Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors